Aim: The aim of the present study was to compare breast cancer in elderly patients to their younger counterparts, and look for factors affecting the survival of elderly patients. Patients and Methods: A retrospective study of breast cancer patients who had surgery at a university hospital from 2000 to 2015 was performed. Stage on presentation, tumour characteristics and modalities of treatment for patients aged >70 years were compared with those aged <70 years. Factors affecting breast cancer specific survival were assessed by multivariate Cox regression. Results: In total, 3825 patients with breast cancer underwent surgery during the study period; 510 patients (13.3 per cent) were aged >70 years . The 5-year overall survival for elderly patients was 76.9 per cent, which was poorer than their younger counterparts (89.5 per cent, P = 0.000). Multivariate analysis demonstrated that the use of adjuvant hormonal therapy (P = 0.001, hazard ratio: 0.481), advanced T-stage (P < 0.05) and advanced N-stage (P < 0.001) were the independent factors affecting breast cancer-specific survival in elderly patients. Conclusions: Elderly breast cancer patients had worse overall and breast cancer-specific survival. Stage on presentation and the use of adjuvant hormonal therapy were independent factors affecting survival among elderly patients. Early diagnosis and comprehensive geriatric assessment to guide the optimal treatment plan would be useful for better survival outcomes in elderly breast cancer patients.
Introduction
Breast cancer is an increasing health burden in Hong Kong (HK) . As shown in the latest report published by the HK Cancer Registry, breast cancer is the leading cause of cancer in women, comprising 26.6 per cent of all cancers in women. 1 The lifetime risk of women in HK developing breast cancer is one in 16.
Ageing is also of public health concern in HK. From the latest published HK population projections, the proportion of the population >70 years is projected to rise from 10.5 per cent to 15.8 per cent in the next 10 years. 2 As the rate of breast cancer has increased, and the elderly population has also increased, we expect the number of older people with breast cancer to increase as well. This postulation is also supported by data provided by the HK Cancer Registry, which demonstrated that there is a steadily rising trend of patients diagnosed with carcinoma of the breast with increasing age. From 2005 to 2015, approximately 18 per cent of all breast cancer patients diagnosed in HK were aged >70 years. 1 Despite the increasing incidence, the knowledge of the best management for breast cancer among the elderly is still limited, as fewer studies have been conducted in the older age group compared to their younger counterparts. A recent local paper concluded that elderly patients tend to delay in their first medical consultation and receive less aggressive cancer treatment. 3 Some Western studies have shown that tumours among older patients have more favourable histological features. 4, 5 However, a lower survival rate was observed in the older age group. 6 To date, the survival of elderly breast cancer patients has not been reported in our locality. The aim of the present study was to look at the survival of elderly patients who received treatment at our centre. Moreover, we investigated the factors affecting the survival so as to find ways to improve our health care in order to improve outcomes among older patients.
Methods
We retrospectively reviewed prospectively-collected data from our centre's database, including patients with carcinoma of the breast who underwent operations in the Division of Breast Surgery, University of HK, from January 2000 to December 2015. The parameters that we recorded included pathological stage, tumour characteristics, modalities of treatment and survival. The patients were grouped according to their age on presentation. The study group was <70 years and the comparison group was >70 years.
Comparisons between the two groups were performed by Fisher's exact test or χ 2 -test when appropriate. Kaplan-Meier analysis was used to compare the 5-year overall and breast cancer-specific survivals. Logistic regression analysis was adopted to identify factors affecting survival. SPSS version 21 (SPSS, Chicago, IL, USA) was used for the statistical analysis. A P-value <0.05 was considered statistically significant.
Results
From January 2000 to December 2015, 3825 patients with carcinoma of the breast were operated on at the Division of Breast Surgery, University of HK; 510 patients, accounting for 13.3 per cent of all patients, were aged >70 years.
A comparison of pathological stage and tumour characteristics between the <70-year and ≥70-year age groups is shown in Table 1 . More patients in the older age group presented with T 4 (P = 0.002) and N 3 (P = 0.012) diseases. No difference was observed in terms of oestrogen and progesterone receptor status between these two groups. Positive human epidermal growth factor receptor 2 (HER2) status is defined as score 3 in immunohistochemical (IHC) test or positive fluorescence in situ hybridization (FISH) test. There was less HER2-positive tumours in the older age group (P = 0.007).
The comparison of modalities of treatment between the two groups is shown in Table 2 . More elderly patients had mastectomy performed (14.7 per cent) compared to their younger counterparts (P = 0.000). Only 2.4 per cent of our elderly patients received neoadjuvant chemotherapy (P = 0.000), whereas a significant larger portion of elderly patients received neoadjuvant hormonal treatment (P = 0.000). For adjuvant treatment, older patients were given significantly less adjuvant radiotherapy (P = 0.000) and less adjuvant chemotherapy (P = 0.000) compared to the younger age group; 65.9 per cent of elderly patients received adjuvant hormonal treatment (P = 0.001).
The 5-year overall survival for the ≥70-year age group was 76.9 per cent, which was significantly lower than that of the <70-year age group, which was 89.5 per cent (P = 0.000) (Fig. 1) . The 5-year breast cancer-specific survival for the ≥70-year age group (82.2 per cent), was also significantly lower than that of the <70-year age group (90.3 per cent, P = 0.000) (Fig. 2) . The Kaplan-Meier estimates of overall survival by stage at diagnosis are shown in Figure 3 . The curves demonstrated that the overall survival for the ≥70-year age group was significantly lower than that of the <70-year age group at stages I, II and III disease at diagnosis, respectively (P = 0.000), whereas at stage IV disease, the two age groups had no significant difference in overall survival (P = 0.299).
A multivariate Cox regression analysis was performed to identify independent factors affecting breast cancer-specific survival in the ≥70-year age group ( Table 3 
Discussion
There is no universal agreement on the definition of 'elderly'. The World Health Organization uses the chronological age of 60 years to define the aging population. 7 The HK Special Administrate Region Government defines the elderly population in HK as those aged >65 years in their population projections report. 2 Chronological age might not be a true reflection of biological age. However, for simplicity and practicality, chronological age is often adopted to define a target population. In our study, we define 'elderly' as those aged >70 years, as the age of 70 years is currently the most common cut-off for the definition of 'elderly' within the field of geriatric onocology. 8 To the best of our knowledge, the present study is that first to investigate the survival outcomes of elderly breast cancer patients in our locality. The 5-year overall survival and breast cancer-specific survival for older patients were significant worse than their younger counterparts. From the multivariate analysis, we found the reasons were twofold: delayed presentation and the use of adjuvant therapy. Our study showed that more elderly patients presented with larger tumours and more advanced lymph node status. Elderly patients had less HER2-positive or less aggressive tumours. Despite having slow-growing tumours with more favourable histological features, elderly patients still presented with more advanced stages of the disease. This finding is consistent with the results published in the HK Breast Cancer Registry Bulletin, 3 where breast tumours were found to be more advanced at presentation in the older population. In that study, 27.5 per cent of the elderly patients waited for more than 1 year for their first medical consultation compared to 10.8 per cent for their younger counterparts. Delayed presentation and lack of awareness significantly contribute to advanced presentation. Attention should be paid to promote breast cancer awareness, not only to the younger age group but also among the elderly and their caretakers.
In the present study, elderly patients received less neoadjuvant chemotherapy, adjuvant radiotherapy and chemotherapy compared to their younger counterparts. It has been reported that undertreatment is not uncommon among older people with breast cancer. 9 There might be several reasons for the substandard treatment. Very often, elderly patients are considered to be frail and with limited life expectancy. Treatment might be perceived to be of doubtful efficacy and uncertain safety. Being undertreated, outcomes in the elderly patients would be compromised.
Management in terms of neoadjuvant and adjuvant treatment modalities was different between the two age groups. In the multivariate analysis, we could only identify the use of adjuvant hormonal therapy as the independent factor in association with poorer survival among elderly patients.
The use of adjuvant hormonal therapy was shown to be a protective factor affecting survival in our study. However, not all elderly patients with oestrogen receptor-positive tumours were commenced on adjuvant hormonal therapy. Sometimes it was not prescribed because of accessibility, and sometimes it was omitted as the medication was considered contraindicated because of comorbidity.
In order to optimize the treatment plan for the elderly, a comprehensive geriatric assessment (CGA) is warranted. The CGA is a quantitative measure of physical and psychosocial functioning for elderly people. Its component can vary, but in general contains various domains, namely functional capacity, cognition, emotional condition, nutritional status and comorbidity. It is considered an objective way to determine the life expectancy of the elderly, and has been recommended by the International Society of Geriatric Oncology and the National Comprehensive Cancer Network to be incorporated in treatment planning. [10] [11] [12] Being a retrospective study, our study was limited by our inability to provide data on comorbidity, which was not prospectively collected over the study period.
In conclusion, elderly patients with carcinoma of the breast have poorer overall and breast cancerspecific survival outcome compared to their younger counterparts. Pathological stage and administration of adjuvant hormonal therapy affects the survival outcome among elderly patients. An increase in the number of geriatric breast cancer patients is imminent, and the aim to achieve an earlier diagnosis and the introduction of the CGA to guide the treatment plan is likely to result in better treatment outcomes among elderly breast cancer patients. 
